This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Unspecified visual impairment (binocular)
H7_BLINDVISIMPNAS
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
590 |
4. Check minimum number of eventsNone |
590 |
5. Include endpointsNone |
590 |
6. Filter based on genotype QC (FinnGen only) |
558 |
Control definitions (FinnGen only)
- Control exclude
- H7_VISUALDISTBLIND
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Unspecified visual impairment (binocular)
based on the number of shared cases.
Similar with more cases:
- Visual impairment including blindness (binocular or monocular)
- Visual disturbances and blindness
- Diseases of the eye and adnexa
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 558 | 321 | 237 |
| Unadjusted period prevalence (%) | 0.11 | 0.11 | 0.11 |
| Median age at first event (years) | 59.75 | 58.45 | 61.51 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 590
- Matched controls
- 5900
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H54.7
ICD-10 Finland
Unspecified visual loss
12350.0
307.7
570
9
XCW99
NOMESCO Finland
Other investigative procedure of eye
9.2
132.2
200
311
H53.1
ICD-10 Finland
Subjective visual disturbances
22.3
115.0
88
46
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
7.8
94.9
156
260
XCK00
NOMESCO Finland
Perimetry
10.1
92.8
116
139
Z01.0
ICD-10 Finland
Examination of eyes and vision
5.6
88.2
233
611
XCK10
NOMESCO Finland
Photography of fundus of eye
6.2
70.3
141
283
XCH00
NOMESCO Finland
Eye pressure measurement
9.0
65.6
87
111
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
7.6
60.5
94
144
XCD10
NOMESCO Finland
Electrophysiological examination of eye
11.0
44.6
49
48
TCG40
NOMESCO Finland
Measurement of higher-grade errors of refraction
81.2
40.5
45
6
H36.01
ICD-10 Finland
Diabetic maculopathy
14.6
40.3
37
27
H53.4
ICD-10 Finland
Visual field defects
112.9
39.3
42
*
Z96.1
ICD-10 Finland
Presence of intraocular lens
3.7
38.6
154
517
H53.9
ICD-10 Finland
Visual disturbance, unspecified
10.7
37.6
42
42
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
88.1
37.3
41
5
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
5.7
34.9
69
133
H35.31
ICD-10 Finland
Senile macular degeneration (atrophic)(exudative)
5.9
33.3
64
120
Z3229
NOMESCO Finland
Other healthcare associate professional
4.0
31.5
100
284
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
34.7
30.4
39
12
H26.02
ICD-10 Finland
Presenil cataract
8.6
29.8
39
48
ZXD10
NOMESCO Finland
Scheduled procedure
2.6
29.3
285
1541
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
2.6
28.1
248
1273
H53.0
ICD-10 Finland
Amblyopia ex anopsia
152.2
27.9
29
*
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
6.6
26.5
44
71
H35.30
ICD-10 Finland
Kuhnt-Junius degeneration
4.6
26.1
66
157
A28
ICPC
Limited function/disability NOS
2.9
25.5
145
589
H53.2
ICD-10 Finland
Diplopia
37.5
25.5
32
9
H52.0
ICD-10 Finland
Hypermetropia
8.0
25.3
35
46
Z71.8
ICD-10 Finland
Other specified counselling
2.5
25.3
233
1208
H26.4
ICD-10 Finland
After-cataract
3.6
25.2
95
302
H47.2
ICD-10 Finland
Optic atrophy
260.6
24.9
25
*
N03AX14
ATC
levetiracetam; systemic
7.6
24.8
36
50
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
7.3
24.0
36
52
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.8
24.0
79
229
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
3.2
23.8
111
402
R51.80
ICD-10 Finland
Headache
2.9
23.7
132
529
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
6.7
22.9
37
58
H25.0
ICD-10 Finland
Senile incipient cataract
4.3
22.9
63
160
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.4
22.8
285
1676
N03AG01
ATC
valproic acid; systemic, rectal
4.3
22.7
63
161
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
4.6
22.6
57
135
H04.10
ICD-10 Finland
Dry eye syndrome
3.3
21.9
94
323
L28
ICPC
Limited function/disability (L)
2.7
21.8
138
590
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
24.2
21.5
30
13
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.5
21.4
81
257
ZXE00
NOMESCO Finland
One hour or less
2.3
21.3
271
1592
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.6
21.3
76
232
CJB10
NOMESCO Finland
Laser discission of secondary cataract
3.5
21.1
79
249
Z2446
NOMESCO Finland
Social worker
3.5
20.9
78
245
R42
ICD-10 Finland
Dizziness and giddiness
2.5
20.7
166
795
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
7.2
20.5
31
45
S01EC01
ATC
acetazolamide; systemic
6.4
20.5
35
58
H25.1
ICD-10 Finland
Senile nuclear cataract
2.4
20.5
205
1084
ZXE10
NOMESCO Finland
More than one and less than three hours
2.2
19.6
248
1442
CA1TM
NOMESCO Finland
Calculation of intraocular lens power
8.7
19.4
25
30
N03AF02
ATC
oxcarbazepine; oral
5.3
18.6
38
75
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.3
18.5
77
259
H52.2
ICD-10 Finland
Astigmatism
6.2
17.9
31
52
H35.5
ICD-10 Finland
Hereditary retinal dystrophy
68.8
17.8
20
*
H3601, H547,
ICD-10 Finland
+∞
17.8
17
*
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
6.5
16.9
28
45
S01ED01
ATC
timolol; ophthalmic
4.8
16.6
38
83
N05BA09
ATC
clobazam; oral
20.8
16.5
24
12
H35.39
ICD-10 Finland
Degeneration of macula and posterior pole
5.2
16.4
34
68
Z3231
NOMESCO Finland
Registered nurse
2.1
16.0
199
1131
R4110
NOMESCO Finland
Physiotherapy
2.2
15.9
190
1062
H57.1
ICD-10 Finland
Ocular pain
4.4
15.8
40
95
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
4.0
15.6
45
118
S01ED51
ATC
timolol, combinations; ophthalmic
3.2
15.5
66
224
S01EA05
ATC
brimonidine; ophthalmic
5.7
15.4
29
53
H43.1
ICD-10 Finland
Vitreous haemorrhage
5.6
15.1
29
54
Z2221
NOMESCO Finland
Medical doctor
2.1
14.9
185
1046
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
2.8
14.8
82
323
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
2.0
14.8
225
1371
N03AX09
ATC
lamotrigine; oral
4.1
14.7
42
109
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.4
14.7
113
523
XF400
NOMESCO Finland
ECG with 12 standard connections
2.4
14.7
120
571
G40.9
ICD-10 Finland
Epilepsy, unspecified
4.7
14.4
34
76
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
28.0
14.4
19
7
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
13.8
14.3
24
18
Z13.1
ICD-10 Finland
Special screening examination for diabetes mellitus
5.9
14.3
26
46
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
6.9
14.1
22
33
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.0
14.1
232
1448
R4120
NOMESCO Finland
Occupational therapy
3.4
14.1
54
172
A10AE04
ATC
insulin glargine; parenteral
2.8
13.7
75
293
XA800
NOMESCO Finland
Neuropsychological investigation
3.8
13.7
43
120
H54.0
ICD-10 Finland
Blindness, binocular
+∞
13.6
13
*
K99
ICPC
Cardiovascular disease other
5.4
13.6
27
52
H54.3
ICD-10 Finland
Mild or no visual impairment, binocular
143.2
13.5
14
*
CKC12
NOMESCO Finland
Photocoagulation of retina
4.1
13.4
37
94
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
3.1
13.3
58
200
ZXA00
NOMESCO Finland
Right side
2.0
13.2
177
1023
N03AX16
ATC
[U] pregabalin
2.1
13.0
150
819
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
19.6
13.0
19
10
P85
ICPC
Mental retardation
19.6
13.0
19
10
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.0
12.9
179
1046
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.3
12.7
109
527
DFF00
NOMESCO Finland
Pure tone audiometry
2.6
12.6
80
337
H3603, E103,
ICD-10 Finland
20.6
12.5
18
9
J01FF01
ATC
clindamycin; systemic
2.0
12.5
167
961
H52.1
ICD-10 Finland
Myopia
4.1
12.2
34
87
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.2
12.2
125
651
SPAT1229
SPAT
Assessment of need for aid
2.9
12.1
58
211
N05CD08
ATC
midazolam; nasal, systemic
4.7
12.0
28
62
G44.2
ICD-10 Finland
Tension-type headache
2.4
12.0
95
444
N05BA04
ATC
oxazepam; oral
2.0
11.9
164
951
AA1AD
NOMESCO Finland
CT of head and brain
2.0
11.9
159
912
Z3226
NOMESCO Finland
Physiotherapist
2.1
11.8
132
710
N02AX02
ATC
tramadol; systemic, rectal
1.9
11.8
253
1700
ZXD05
NOMESCO Finland
Urgent procedure
1.9
11.7
190
1165
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.3
11.7
46
149
TAB00
NOMESCO Finland
Lumbar puncture
3.5
11.6
41
124
S01EE01
ATC
latanoprost; ophthalmic
3.1
11.5
51
177
F05
ICPC
Visual disturbance other
4.3
11.5
30
73
114
Kela drug reimbursment
Glaucoma
2.7
11.3
65
261
EBA15
NOMESCO Finland
Extraction of multiple teeth
3.9
11.2
33
88
T89
ICPC
Diabetes insulin dependent
3.6
11.2
37
107
Z2445
NOMESCO Finland
Psychologist
3.2
11.1
45
148
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.9
11.1
55
204
XCD20
NOMESCO Finland
Photoangiography of eye
5.4
10.7
21
40
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
3.7
10.6
34
96
WX199
NOMESCO Finland
Other local analgesia
4.2
10.5
28
69
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
10.5
164
988
ZXA10
NOMESCO Finland
Bilateral
2.0
10.4
127
702
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
10.4
135
763
ZYC01
NOMESCO Finland
Remote contact by phone
2.9
10.4
50
182
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.8
10.3
53
200
C08CA13
ATC
lercanidipine; oral
2.2
10.2
93
459
R60.0
ICD-10 Finland
Localized oedema
2.3
10.2
81
378
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
4.5
10.1
25
58
J01MA02
ATC
ciprofloxacin; systemic
1.8
10.1
221
1477
RT274, ,
NOMESCO Finland
40.8
10.0
12
*
N05AH04
ATC
quetiapine; oral
2.1
9.9
114
616
H33.0
ICD-10 Finland
Retinal detachment with retinal break
3.9
9.9
29
77
UJD02
NOMESCO Finland
Gastroscopy
3.2
9.8
39
127
WX140
NOMESCO Finland
Parabulbar anesthesy
3.2
9.8
39
127
XF600
NOMESCO Finland
Bloodpressure measurement
2.7
9.8
55
218
H02AB06
ATC
prednisolone; systemic
1.7
9.8
274
1962
H53.8
ICD-10 Finland
Other visual disturbances
13.7
9.7
16
12
ZXA05
NOMESCO Finland
Left side
1.9
9.7
151
906
CKD40
NOMESCO Finland
Endophotocoagulation of retina
8.0
9.7
21
27
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
55.9
9.7
11
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
9.6
200
1312
WX002
NOMESCO Finland
Sedation and analgesia
2.0
9.6
121
676
N05CD07
ATC
temazepam; oral
2.3
9.6
81
388
H55
ICD-10 Finland
Nystagmus and other irregular eye movements
15.3
9.6
15
10
H47.7
ICD-10 Finland
Disorder of visual pathways, unspecified
101.6
9.4
10
*
G80.0
ICD-10 Finland
Spastic quadriplegic cerebral palsy
101.6
9.4
10
*
SPAT1100
SPAT
Long-term monitoring of blood pressure
2.8
9.4
48
181
N06AX26
ATC
vortioxetine; oral
2.8
9.4
48
181
WX892
NOMESCO Finland
Monitored bed care
2.7
9.3
52
205
ZY010
NOMESCO Finland
Hospital outpatient
2.9
9.3
46
170
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.1
9.3
92
470
L17
ICPC
Foot/toe symptom/complaint
1.8
9.2
180
1156
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.4
9.2
67
301
UKC02
NOMESCO Finland
Cystoscopy
2.1
9.1
94
487
CK2L4
NOMESCO Finland
Wide-field/panoramic imaging of ocular fundus
15.9
9.1
14
9
RT490, ,
NOMESCO Finland
37.3
9.0
11
*
WX110
NOMESCO Finland
Infiltration anesthesia
1.8
9.0
407
3292
A10AB05
ATC
insulin aspart; parenteral
2.5
9.0
57
239
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.8
9.0
46
173
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
2.6
8.9
54
222
S18
ICPC
Laceration/cut
1.7
8.9
261
1878
R5140
NOMESCO Finland
Monitoring the use of the aid
2.3
8.9
71
332
N03AX12
ATC
[U] gabapentin; oral
2.0
8.8
100
536
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.4
8.8
61
268
N03AX18
ATC
lacosamide; systemic
14.3
8.7
14
10
H3601, E116,
ICD-10 Finland
50.8
8.7
10
*
R52.9
ICD-10 Finland
Pain, unspecified
2.4
8.6
63
283
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
7.1
8.6
20
29
A10AE06
ATC
insulin degludec; parenteral
3.5
8.6
29
85
Z97.4
ICD-10 Finland
Presence of external hearing-aid
3.0
8.5
39
138
Z00.8
ICD-10 Finland
Other general examinations
2.5
8.5
55
233
TKC20
NOMESCO Finland
Catheterisation of bladder
2.6
8.5
50
203
M79.6
ICD-10 Finland
Pain in limb
1.7
8.4
237
1679
G80.1
ICD-10 Finland
Spastic diplegic cerebral palsy
91.3
8.4
9
*
H54.4
ICD-10 Finland
Blindness, monocular
91.3
8.4
9
*
A10AC01
ATC
insulin (human); parenteral
2.4
8.4
57
248
UJF30
NOMESCO Finland
Ileoscopy through colon
2.3
8.3
63
287
ZXD35
NOMESCO Finland
Usual procedure
3.6
8.3
27
77
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.8
8.3
136
825
B01AF02
ATC
apixaban; oral
2.2
8.3
74
362
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.8
8.3
171
1112
SPAT1301
SPAT
No procedures
1.7
8.2
188
1257
H50.1
ICD-10 Finland
Divergent concomitant strabismus
14.7
8.2
13
9
C07AB07
ATC
bisoprolol; oral
1.7
8.1
273
2021
H50.0
ICD-10 Finland
Convergent concomitant strabismus
11.9
8.1
14
12
BEF00
NOMESCO Finland
Continuous subcutaneous glucose monitoring
11.9
8.1
14
12
CKD15
NOMESCO Finland
Injection of vitreous substitute
17.5
8.1
12
7
R06.0
ICD-10 Finland
Dyspnoea
1.8
8.1
162
1043
N03AG04
ATC
vigabatrin; oral
33.8
8.1
10
*
N06AX21
ATC
duloxetine; oral
2.2
8.1
71
345
WX100
NOMESCO Finland
Conjunctival surface anesthesia
2.1
8.1
79
401
R13
ICD-10 Finland
Dysphagia
2.6
8.1
49
202
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.6
8.0
300
2278
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
3.4
8.0
29
89
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
8.0
164
1062
SPAT1262
SPAT
Handing over of treatment supplies
2.0
8.0
103
577
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.1
8.0
78
395
R5110, ,
SPAT
2.7
8.0
42
161
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.8
7.9
144
900
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
4.0
7.9
22
56
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
3.7
7.9
25
70
H3601, E103,
ICD-10 Finland
13.3
7.9
13
10
Z49.0
ICD-10 Finland
Preparatory care for dialysis
13.3
7.9
13
10
TCW99
NOMESCO Finland
Other minor procedure in eye surgery
7.1
7.8
18
26
H46
ICD-10 Finland
Optic neuritis
9.6
7.8
15
16
N30.0
ICD-10 Finland
Acute cystitis
2.0
7.8
96
530
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
15.3
7.7
12
8
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
4.4
7.7
19
44
RS221, ,
NOMESCO Finland
4.4
7.7
19
44
G80.9
ICD-10 Finland
Cerebral palsy, unspecified
45.6
7.7
9
*
181
Kela drug reimbursment
Retigabine and vigabatrin
45.6
7.7
9
*
F83
ICD-10 Finland
Mixed specific developmental disorders
7.6
7.7
17
23
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
4.6
7.7
18
40
D64.9
ICD-10 Finland
Anaemia, unspecified
2.2
7.7
70
345
S29
ICPC
Skin symptom/complaint other
1.9
7.7
114
670
G40.4
ICD-10 Finland
Other generalized epilepsy and epileptic syndromes
18.6
7.6
11
6
H36.00
ICD-10 Finland
Diabetic background retinopathy
6.3
7.6
19
31
A11CC03
ATC
alfacalcidol; systemic
4.2
7.6
20
49
RT150, ,
NOMESCO Finland
10.2
7.6
14
14
R07.4
ICD-10 Finland
Chest pain, unspecified
1.7
7.5
158
1028
N06AB04
ATC
citalopram; systemic
1.8
7.5
123
744
A02BC02
ATC
pantoprazole; systemic
1.6
7.5
365
2939
K29
ICPC
Cardiovascular sympt/complt other
3.3
7.5
28
88
N02BF02
ATC
pregabalin; oral
2.8
7.5
38
143
H40.13
ICD-10 Finland
Chronic glaucoma with open ventricular angle
2.9
7.5
35
126
N05BA01
ATC
diazepam; systemic, rectal
2.0
7.4
84
449
WX402
NOMESCO Finland
General anaesthesia
1.8
7.4
118
707
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.7
7.4
40
155
M41.4
ICD-10 Finland
Neuromuscular scoliosis
81.1
7.4
8
*
WX006
NOMESCO Finland
Intravenous sedation or analgesia without general anesthesia
2.8
7.4
36
132
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
13.6
7.4
12
9
K02.1
ICD-10 Finland
Caries of dentine
1.6
7.4
328
2579
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.9
7.4
94
524
H40.0
ICD-10 Finland
Glaucoma suspect
2.4
7.4
50
217
R55
ICD-10 Finland
Syncope and collapse
2.1
7.4
74
379
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.9
7.3
98
556
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
9.5
7.3
14
15
183
Kela drug reimbursment
Lamotrigin and topiramate
9.5
7.3
14
15
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
7.3
154
1003
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.2
7.3
29
95
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.6
7.3
41
163
EB1AA, ,
SPAT
2.5
7.2
46
194
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
8.1
7.1
15
19
N02AJ06
ATC
codeine and paracetamol; systemic
1.6
7.1
228
1653
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.9
7.1
33
118
N06AX11
ATC
mirtazapine; oral
1.7
7.1
190
1318
M54.4
ICD-10 Finland
Lumbago with sciatica
1.9
7.1
96
547
H57.9
ICD-10 Finland
Disorder of eye and adnexa, unspecified
10.2
7.1
13
13
F10.09
ICD-10 Finland
Alcohol intoxication UNS
4.3
7.1
18
43
J01MA14
ATC
moxifloxacin; systemic
2.3
7.0
56
261
U07
ICPC
Urine symptom/complaint other
2.4
7.0
48
209
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
3.4
7.0
25
76
CKD65
NOMESCO Finland
Pars plana or pars plicata vitrectomy
3.9
7.0
20
52
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.7
7.0
38
148
A10AE05
ATC
insulin detemir; parenteral
2.6
7.0
41
166
UDC00
NOMESCO Finland
Ear microscopy
2.3
7.0
53
242
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.5
6.9
43
179
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
1.8
6.9
112
674
A69
ICPC
General and Unspecified, Other reason for encounter NEC
3.5
6.9
23
67
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.6
6.9
182
1257
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
6.9
114
692
S21
ICPC
Skin texture symptom/complaint
1.9
6.8
86
478
CKD10
NOMESCO Finland
Insufflation of vitreous cavity
5.8
6.8
18
32
N06AB05
ATC
paroxetine; oral
2.8
6.8
34
127
K90
ICPC
Stroke/cerebrovascular accident
3.6
6.8
22
63
A10AB04
ATC
insulin lispro; parenteral
3.3
6.8
25
78
N06AX16
ATC
venlafaxine; oral
2.0
6.8
81
442
CK2A4
NOMESCO Finland
Autofluorescence imaging of ocular fundus
16.9
6.8
10
6
Z01.2
ICD-10 Finland
Dental examination
1.6
6.7
259
1955
N02BE01
ATC
paracetamol; systemic, rectal
1.8
6.7
495
4370
S06.0
ICD-10 Finland
Concussion
2.0
6.7
72
378
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
22.8
6.7
9
*
N03AE01
ATC
clonazepam; systemic
2.7
6.7
35
134
S01AD03
ATC
aciclovir; ophthalmic
3.3
6.6
25
79
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
3.5
6.6
22
64
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
6.6
122
763
B01AC04
ATC
clopidogrel; oral
1.9
6.6
95
551
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
4.2
6.6
17
41
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
8.8
6.6
13
15
H20.1
ICD-10 Finland
Chronic iridocyclitis
8.8
6.6
13
15
J01AA02
ATC
doxycycline; systemic
1.6
6.6
411
3462
I10
ICD-10 Finland
Essential (primary) hypertension
1.6
6.6
318
2525
R21
NOMESCO Finland
Counselling and guidance in rehabilitation
10.2
6.6
12
12
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.8
6.5
105
630
X59
ICD-10 Finland
Exposure to unspecified factor
1.8
6.5
110
670
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
3.7
6.5
20
55
F29
ICPC
Eye symptom/complaint other
2.1
6.5
65
332
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
3.2
6.5
25
80
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
2.3
6.5
52
243
D50.8
ICD-10 Finland
Other iron deficiency anaemias
6.3
6.5
16
26
C03CA01
ATC
furosemide; systemic
1.6
6.4
172
1187
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.0
6.4
71
377
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.9
6.4
79
436
C08CA01
ATC
amlodipine; oral
1.6
6.4
202
1453
H13
ICPC
Plugged feeling ear
1.8
6.4
109
667
A10AA02, ,
ATC
3.0
6.3
27
92
A10AB01
ATC
insulin (human); parenteral
3.0
6.3
27
92
R32
ICD-10 Finland
Unspecified urinary incontinence
3.4
6.3
22
66
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.9
6.3
28
98
N05AA02
ATC
levomepromazine; systemic
2.9
6.3
28
98
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.7
6.2
140
924
H40.9
ICD-10 Finland
Glaucoma, unspecified
4.0
6.2
17
43
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
4.0
6.2
17
43
XG460
NOMESCO Finland
Short time oxymetry
4.0
6.2
17
43
WX290
NOMESCO Finland
Other blockage of nerve
1.5
6.2
251
1909
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
12.7
6.1
10
8
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
12.7
6.1
10
8
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
8.7
6.1
12
14
R02
ICPC
Shortness of breath/dyspnoea
1.9
6.0
77
429
M02AA10
ATC
ketoprofen; topical
1.9
6.0
86
497
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.7
6.0
111
693
M79.1
ICD-10 Finland
Myalgia
1.9
6.0
82
467
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
192
845
2.89
29.67
5.5
3.7
1031.46
340.37
ng/l
0.36
148
655
105
375
3.19
23.00
3.6
2.8
281.40
212.77
ng/l
0.61
96
343
395
2674
2.44
22.77
7.2
5.1
7.04
6.66
mmol/l
1.82
378
2484
191
975
2.42
20.69
4.3
2.5
4.26
6.02
e6/l
1.12
174
885
250
1436
2.29
20.57
5.3
3.1
13.82
95.89
e6/l
1.12
208
1104
287
1770
2.21
19.58
2.3
2.0
91.06
94.86
pmol/l
0.74
146
907
201
1080
2.31
19.11
2.8
2.3
—
—
—
0
0
274
1673
2.19
19.01
6.1
3.7
56.62
114.92
e6/l
1.11
211
1181
228
1294
2.24
18.98
2.6
2.0
202.28
322.30
u/l
0.78
221
1219
342
2284
2.18
18.81
10.9
7.3
1.21
1.22
mmol/l
0.71
304
1958
93
357
2.91
17.75
2.3
2.3
5.34
6.63
ug/l
0.36
83
311
59
179
3.55
16.61
2.7
1.9
—
—
—
0
0
261
1667
2.01
15.09
5.0
3.1
—
—
—
0
0
290
1932
1.99
14.77
6.1
4.6
35.40
35.67
g/l
0.35
268
1799
283
1891
1.95
14.08
2.8
2.4
72.60
76.02
nmol/l
1.27
260
1698
151
810
2.16
13.78
3.1
2.9
2.48
2.45
mmol/l
1.49
132
701
52
166
3.34
13.50
2.7
1.8
—
—
—
0
0
105
488
2.40
13.47
6.7
5.4
1.44
1.94
mmol/l
0.82
91
390
126
646
2.21
12.79
7.8
6.1
1.08
1.09
mmol/l
0.16
119
594
211
1310
1.95
12.74
5.0
3.1
0.15
0.52
e6/l
4.28
169
981
190
1148
1.97
12.36
4.8
4.1
93.19
90.40
%
0.82
182
1121
132
704
2.13
12.07
2.9
4.2
0.81
0.82
mmol/l
0.17
122
662
88
396
2.44
12.06
10.9
5.6
5.08
5.13
kpa
0.22
83
377
94
436
2.38
12.05
3.0
1.9
354.07
378.93
nmol/l
0.51
89
404
87
390
2.44
12.02
8.7
9.1
1.23
1.35
mmol/l
0.73
82
380
91
418
2.39
11.91
2.8
2.3
29.13
30.15
u/l
0.08
78
347
545
4759
2.90
11.48
26.2
15.8
139.20
139.67
mmol/l
4.11
538
4617
540
4702
2.75
11.28
22.3
13.5
23.25
23.47
mg/l
0.06
441
3652
545
4770
2.87
11.21
26.5
15.9
3.96
3.97
mmol/l
0.24
535
4617
87
403
2.36
11.15
9.0
7.4
9.57
8.91
mmol/l
0.36
81
381
70
294
2.57
11.08
9.5
6.1
23.96
23.81
mmol/l
0.20
70
289
321
2353
1.80
10.95
5.4
6.3
12.91
12.33
umol/l
0.20
308
2221
434
3494
1.92
10.83
8.5
7.1
85.93
82.31
u/l
0.53
409
3258
424
3402
1.88
10.51
5.1
4.1
14.10
11.92
mm/h
2.07
386
3124
290
2087
1.77
10.33
16.0
13.2
1.28
1.26
inr
0.23
137
620
81
381
2.31
9.99
11.5
5.8
1.30
1.73
mmol/l
0.50
55
276
495
4211
2.09
9.95
22.2
12.5
80.50
81.05
ml/min/173m2
0.18
423
3409
129
730
1.98
9.87
2.3
1.9
—
—
—
0
0
132
754
1.97
9.83
4.2
2.9
3.48
2.05
e6/l
0.49
66
405
186
1188
1.83
9.82
3.1
2.2
2.61
3.04
mg/l
1.78
160
1018
355
2738
1.74
9.63
8.8
9.2
4.09
4.03
e9/l
0.18
305
2388
312
2327
1.72
9.51
6.9
6.1
28.26
28.67
%
0.26
291
2190
36
116
3.24
9.22
1.2
1.9
425.69
463.10
mg/l
0.29
36
110
307
2294
1.71
9.17
6.6
5.9
56.88
56.45
%
0.23
289
2163
135
794
1.91
9.17
4.3
2.8
0.98
0.93
e6/l
0.08
71
444
140
837
1.88
9.03
1.7
1.8
941.21
1157.24
nmol/l
2.12
108
635
20
43
4.78
8.88
1.0
1.1
—
—
—
0
0
281
2076
1.68
8.56
10.0
7.1
1.21
1.22
mmol/l
0.56
257
1890
491
4234
1.95
8.48
5.5
4.6
1.88
2.22
mu/l
0.63
460
3862
18
37
4.99
8.41
1.0
1.1
—
—
—
0
0
19
41
4.76
8.40
1.0
1.1
—
—
—
0
0
32
103
3.23
8.22
1.2
1.9
3.41
3.99
e6/l
0.14
22
82
32
103
3.23
8.22
1.3
2.0
289.22
1234.22
e6/l
0.43
23
85
51
214
2.51
8.08
13.1
12.1
24.06
24.55
mmol/l
0.51
46
208
124
738
1.86
8.03
3.2
2.4
12.08
13.13
umol/l
0.88
116
684
42
164
2.68
7.69
1.7
1.8
—
—
—
0
0
421
3509
1.70
7.63
4.4
3.8
14.44
14.75
pmol/l
1.73
391
3175
114
675
1.85
7.47
3.2
2.3
2.28
2.36
g/l
0.86
107
620
108
639
1.84
7.07
3.3
2.4
20.94
22.83
%
0.73
97
548
565
5225
2.92
6.96
31.3
19.9
249.18
251.03
e9/l
0.26
550
5069
271
2057
1.59
6.93
3.5
2.8
128.46
116.05
ug/l
0.29
257
1900
565
5229
2.90
6.87
31.3
19.9
4.43
4.49
e12/l
1.77
550
5057
565
5232
2.89
6.80
31.5
20.1
132.50
134.65
g/l
2.73
559
5143
540
4904
2.19
6.79
13.4
9.9
27.61
25.57
u/l
0.72
522
4716
42
176
2.49
6.69
1.7
2.2
43.86
38.40
u/l
0.66
37
156
69
357
2.06
6.68
1.9
3.1
65.55
66.39
g/l
0.34
64
321
564
5224
2.81
6.67
32.1
20.1
39.56
40.00
%
1.03
547
4881
45
197
2.39
6.53
1.3
2.2
1.45
1.55
g/l
0.25
39
177
68
353
2.05
6.52
4.0
4.3
124.55
76.63
ng/l
2.13
62
314
87
493
1.90
6.50
2.6
4.2
317.02
249.15
u/l
0.48
81
473
362
2974
1.56
6.31
3.6
3.1
55.72
46.35
u/l
1.09
341
2770
154
1048
1.64
6.05
1.6
1.6
21.24
20.81
nmol/l
0.13
139
896
212
1557
1.56
6.05
2.7
3.2
2.37
2.36
mmol/l
0.91
184
1369
194
1397
1.58
6.03
4.7
3.2
6.89
7.47
mmol/l
0.89
178
1179
16
29
5.64
6.03
1.1
1.0
—
—
—
0
0
83
475
1.87
6.00
9.3
9.6
12.30
12.19
kpa
0.07
78
457
83
475
1.87
6.00
9.3
9.6
4.96
5.12
kpa
0.66
78
457
181
1295
1.57
5.74
3.1
3.3
1789.22
1299.82
ng/l
0.57
154
1109
465
4097
1.64
5.59
7.5
5.6
41.50
39.82
mmol/mol
2.20
437
3816
61
324
1.98
5.50
2.9
2.6
80.62
65.52
ml/min/173m2
2.80
29
124
267
2102
1.49
5.35
2.9
2.5
—
—
—
0
0
486
4352
1.66
5.23
4.9
4.3
6.20
5.93
mmol/l
2.05
445
3963
27
106
2.62
4.95
1.9
2.5
186.23
56.33
ug/min
1.02
18
61
86
528
1.74
4.92
2.1
3.2
10.08
9.67
umol/l
0.03
71
451
79
475
1.77
4.86
9.6
9.6
0.52
1.33
mmol/l
0.75
62
391
13
25
5.29
4.79
1.1
1.3
—
—
—
0
0
25
98
2.62
4.61
1.8
1.3
—
—
—
0
0
25
98
2.62
4.61
1.8
1.3
—
—
—
0
0
8
8
10.12
4.53
1.1
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
29
124
2.41
4.48
2.8
3.8
0.42
0.31
u/ml
0.34
14
74
141
1002
1.54
4.47
1.7
1.9
1.10
1.17
mg/l
0.14
106
769
186
1403
1.48
4.42
3.1
2.4
54.15
59.33
u/l
0.63
177
1304
14
34
4.19
4.23
1.1
1.5
110.21
71.09
umol/l
2.06
14
34
490
4472
1.56
4.03
5.5
4.7
2.56
2.74
mmol/l
4.36
456
4112
152
1122
1.48
3.98
3.3
2.7
357.16
7315.96
umol/l
4.98
134
973
54
314
1.79
3.74
1.8
1.6
—
—
—
0
0
18
69
2.66
3.50
1.2
1.3
—
—
—
0
0
462
4216
1.44
3.31
4.4
3.8
1.36
1.28
mmol/l
1.12
421
3859
169
1316
1.40
3.24
5.7
3.8
17.22
9.14
mg/mmol
0.88
125
834
25
117
2.19
3.21
1.6
1.3
—
—
—
0
0
76
506
1.58
3.19
2.2
1.8
—
—
—
0
0
478
4400
1.45
3.18
4.9
4.3
4.42
4.63
mmol/l
4.72
446
4077
350
3063
1.35
3.16
3.6
3.2
—
—
—
0
0
185
1469
1.38
3.14
3.2
3.1
30.50
32.60
u/l
0.59
173
1407
11
30
3.72
3.10
2.0
1.8
21.49
20.53
umol/l
0.03
11
30
474
4367
1.43
3.04
4.9
4.2
1.41
1.47
mmol/l
2.00
439
4015
44
258
1.76
3.00
2.2
1.7
—
—
—
0
0
20
88
2.32
2.97
1.3
1.2
—
—
—
0
0
43
252
1.76
2.94
2.3
3.1
4.19
4.54
pmol/l
1.77
35
220
8
17
4.75
2.92
2.0
6.9
—
—
—
0
0
14
52
2.73
2.90
1.1
1.2
—
—
—
0
0
7
13
5.43
2.87
1.0
1.1
1458.71
1428.00
miu/ml
—
7
13
10
28
3.61
2.79
1.8
2.1
—
—
—
0
0
130
993
1.40
2.76
4.4
4.2
23.50
21.30
%
0.59
51
450
149
1165
1.37
2.74
1.3
1.3
4.01
1.46
u/ml
0.66
34
285
26
132
2.01
2.74
1.4
1.4
306.80
286.19
ug/g
0.18
15
74
158
1248
1.36
2.73
4.5
4.8
2.45
2.59
ug/l
0.08
148
1111
59
386
1.59
2.69
11.6
9.6
117.71
121.36
g/l
0.70
59
377
72
498
1.51
2.57
2.0
1.8
1.71
1.50
%
0.87
59
439
6
11
5.50
2.55
1.0
1.2
—
—
—
0
0
22
109
2.06
2.49
2.1
2.0
0.00
0.00
g/l
-0.00
22
100
73
510
1.49
2.49
2.2
1.9
—
—
—
0
0
9
27
3.37
2.40
1.0
1.1
—
—
—
0
0
15
65
2.34
2.33
1.2
1.5
—
—
—
0
0
9
28
3.25
2.31
1.9
2.1
—
—
—
0
0
6
169
0.35
2.31
2.3
1.8
0.61
2.68
mg/l
—
6
126
15
66
2.31
2.26
1.2
1.5
—
—
—
0
0
15
66
2.31
2.26
1.2
1.5
—
—
—
0
0
43
274
1.61
2.21
1.1
1.1
—
—
—
0
0
20
101
2.01
2.18
1.3
1.5
237.89
274.13
u/ml
—
9
47
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
30
3.03
2.15
1.0
1.2
—
—
—
0
0
24
131
1.87
2.11
1.1
1.2
—
—
—
0
0
8
26
3.10
2.02
1.4
2.5
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
7
21
3.36
1.97
2.0
2.4
113.79
118.14
%
—
7
21
20
106
1.92
1.93
1.3
1.5
—
—
—
0
0
18
92
1.99
1.92
1.4
1.6
—
98.21
—
0
19
29
174
1.70
1.90
4.1
8.2
1.50
1.39
mg/l
0.32
29
161
25
144
1.77
1.88
2.1
1.5
0.22
0.10
iu/ml
—
7
34
8
28
2.88
1.86
2.8
2.2
26.38
27.18
umol/l
—
8
28
145
1192
1.29
1.85
1.7
1.6
1.42
1.37
mmol/l
0.17
128
1011
30
184
1.66
1.82
2.0
1.7
14.50
23.52
iu/l
1.26
20
154
24
140
1.74
1.74
2.1
1.7
7.15
8.08
u/l
0.21
17
108
96
752
1.33
1.74
1.3
1.3
34.07
33.48
iu/ml
0.02
25
251
259
2292
1.23
1.73
4.5
3.6
0.00
0.01
estimate
0.50
46
423
256
2264
1.23
1.71
4.5
3.6
0.00
0.00
estimate
0.50
54
464
256
2265
1.23
1.70
6.6
4.9
0.00
0.00
estimate
0.50
51
436
34
221
1.57
1.66
2.1
4.5
1.38
1.21
%
0.40
34
221
25
400
0.61
1.66
1.4
1.6
—
—
—
0
0
33
214
1.57
1.63
2.1
4.6
0.50
0.66
%
2.95
33
214
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
5
14
3.59
1.62
1.0
1.0
110.80
115.86
%
—
5
14
28
177
1.61
1.54
2.7
7.6
1.60
1.53
%
0.11
28
167
52
377
1.42
1.53
5.6
3.9
1.23
1.23
mmol/l
0.22
45
328
6
21
2.88
1.51
3.8
2.6
25.83
35.46
umol/l
—
6
13
9
39
2.33
1.43
2.3
2.7
—
—
—
0
0
5
18
2.79
1.28
1.6
1.2
91.20
72.00
%
—
5
18
5
19
2.64
1.22
1.4
1.5
—
—
—
0
0
12
64
1.89
1.18
1.2
1.5
—
—
—
0
0
0
33
0.00
1.16
0.0
1.2
—
175.44
—
0
33
156
1775
0.84
1.14
5.0
3.7
—
—
—
0
0
12
65
1.86
1.14
1.1
1.5
—
—
—
0
0
12
65
1.86
1.14
1.2
1.5
—
—
—
0
0
38
278
1.39
1.11
1.5
1.4
—
—
—
0
0
5
21
2.39
1.09
2.0
2.3
—
—
—
0
0
8
41
1.96
1.09
1.1
1.6
—
—
—
0
0
20
129
1.57
1.07
1.5
2.0
—
—
—
0
0
9
48
1.89
1.01
1.9
1.8
—
—
—
0
0
9
48
1.89
1.01
1.9
1.8
—
—
—
0
0
9
48
1.89
1.01
1.9
1.8
—
—
—
0
0
85
707
1.24
1.00
1.3
1.2
2.55
11.50
u/ml
2.93
29
275
11
187
0.58
0.99
1.6
1.4
—
—
—
0
0
5
23
2.18
0.98
1.2
1.0
—
—
—
0
0
6
28
2.15
0.91
1.0
1.1
25.67
30.71
u/l
—
6
28
6
28
2.15
0.91
1.0
1.1
56.67
105.38
u/l
—
6
28
40
310
1.31
0.85
2.4
2.2
10.15
12.69
nmol/l
1.18
34
280
108
942
1.18
0.80
1.6
1.7
439.54
439.81
pmol/l
0.00
91
790
19
131
1.47
0.79
1.5
3.1
—
—
—
0
0
6
33
1.83
0.79
3.8
11.9
616.83
884.00
nmol/l
—
6
33
7
125
0.55
0.78
2.1
1.7
93.29
41.37
nmol/l
—
7
119
6
34
1.77
0.76
1.0
1.3
—
—
—
0
0
5
24
2.09
0.74
2.6
4.0
102.20
134.04
nmol/l
—
5
24
5
25
2.01
0.73
1.0
1.1
—
—
—
0
0
7
39
1.80
0.72
4.4
1.4
—
—
—
0
0
9
57
1.59
0.71
1.1
1.2
—
—
—
0
0
9
59
1.53
0.68
1.4
1.2
—
—
—
0
0
5
29
1.73
0.64
2.0
2.4
406.80
795.31
u/ml
—
5
29
8
49
1.64
0.62
2.1
3.4
3.76
7.15
nmol/l
—
8
49
21
156
1.36
0.62
1.4
1.7
—
—
—
0
0
0
21
0.00
0.60
0.0
2.2
—
122.83
—
0
21
12
174
0.68
0.60
1.4
1.9
—
—
—
0
0
19
140
1.37
0.59
1.3
1.1
—
—
—
0
0
6
35
1.72
0.58
1.0
1.3
—
—
—
0
0
20
150
1.35
0.56
1.3
1.1
—
—
—
0
0
8
122
0.65
0.55
1.3
1.8
—
—
—
0
0
6
39
1.54
0.53
1.0
1.0
—
—
—
0
0
6
39
1.54
0.53
1.0
1.1
—
—
—
0
0
6
39
1.54
0.53
1.0
1.1
—
—
—
0
0
16
117
1.38
0.52
1.4
1.4
—
—
—
0
0
6
40
1.51
0.51
1.0
1.1
—
—
—
0
0
6
40
1.51
0.51
1.0
1.1
—
—
—
0
0
6
40
1.51
0.51
1.0
1.1
—
—
—
0
0
18
135
1.34
0.51
1.6
1.3
269.00
272.57
miu/ml
—
8
66
18
135
1.34
0.51
1.3
1.3
—
—
—
0
0
113
1239
0.89
0.50
5.3
3.7
0.00
0.01
estimate
0.69
46
424
38
317
1.21
0.49
1.1
1.2
88.60
149.80
iu/ml
0.90
12
132
52
449
1.17
0.47
4.1
3.4
—
—
—
0
0
7
47
1.50
0.47
2.9
4.3
—
—
—
0
0
10
68
1.48
0.47
1.6
1.5
—
—
—
0
0
53
460
1.17
0.46
2.5
4.0
4.91
22.66
ug/l
1.01
38
386
48
554
0.85
0.45
4.3
4.2
33.56
31.54
%
0.59
34
364
13
95
1.38
0.44
1.8
1.7
—
—
—
0
0
13
95
1.38
0.44
1.8
1.7
—
—
—
0
0
176
1653
1.09
0.43
4.5
3.7
27.23
38.21
ng/l
1.29
120
1148
19
149
1.28
0.42
1.3
1.1
—
—
—
0
0
8
58
1.38
0.41
1.0
1.0
—
—
—
0
0
5
33
1.52
0.41
1.2
2.7
—
—
—
0
0
5
33
1.52
0.41
1.2
2.7
—
—
—
0
0
0
15
0.00
0.41
0.0
3.6
—
204.80
—
0
15
45
516
0.86
0.40
7.2
7.0
—
—
—
0
0
0
19
0.00
0.39
0.0
1.5
—
—
—
0
0
12
89
1.36
0.38
4.4
2.3
14.75
15.94
%
—
6
43
103
949
1.10
0.38
1.9
1.6
—
—
—
0
0
50
564
0.88
0.36
2.7
2.1
—
—
—
0
0
6
43
1.40
0.35
1.8
2.2
—
—
—
0
0
20
241
0.82
0.32
2.9
2.9
14.09
69.46
u/ml
1.99
20
233
13
101
1.29
0.32
1.7
1.4
—
—
—
0
0
78
718
1.10
0.30
3.4
2.9
0.70
0.81
ug/l
0.77
51
457
8
65
1.23
0.27
1.0
1.1
—
—
—
0
0
62
672
0.91
0.25
1.4
1.4
—
—
—
0
0
5
39
1.28
0.23
1.2
3.5
—
—
—
0
0
47
512
0.91
0.21
2.5
2.0
—
—
—
0
0
5
42
1.19
0.21
1.2
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
2.0
—
—
—
0
0
10
80
1.25
0.20
5.6
2.7
3.99
4.44
e9/l
—
10
80
9
115
0.78
0.20
1.7
1.2
—
—
—
0
0
12
99
1.22
0.19
1.2
1.6
—
—
—
0
0
7
61
1.15
0.17
1.3
1.8
—
—
—
0
0
15
129
1.17
0.17
1.5
1.7
—
—
—
0
0
6
79
0.76
0.15
1.0
1.6
—
—
—
0
0
10
83
1.21
0.15
6.2
3.1
52.40
58.20
%
—
10
83
29
265
1.10
0.15
3.2
9.0
25.13
24.79
mmol/l
0.17
29
253
9
82
1.10
0.15
1.2
1.1
—
—
—
0
0
98
1017
0.96
0.13
4.9
3.7
1.01
1.02
kg/l
0.81
20
144
10
117
0.85
0.13
1.0
1.4
—
—
—
0
0
31
289
1.08
0.11
2.3
1.7
—
—
—
0
0
5
44
1.14
0.10
1.0
1.1
—
—
—
0
0
25
268
0.93
0.09
1.3
1.3
—
—
—
0
0
5
62
0.80
0.08
1.0
1.7
—
—
—
0
0
11
123
0.89
0.08
3.4
1.6
—
—
—
0
0
8
94
0.85
0.06
1.3
1.9
—
—
—
0
0
11
99
1.11
0.06
1.6
1.2
—
—
—
0
0
9
101
0.89
0.06
1.7
1.4
—
—
—
0
0
9
101
0.89
0.06
1.7
1.4
—
—
—
0
0
9
101
0.89
0.06
1.7
1.4
—
—
—
0
0
9
101
0.89
0.06
1.7
1.4
—
—
—
0
0
10
111
0.90
0.06
1.8
1.5
—
—
—
0
0
13
141
0.92
0.05
1.2
1.1
—
12.22
—
0
17
12
113
1.06
0.02
1.1
1.4
—
—
—
0
0
13
123
1.06
0.01
2.3
1.5
—
—
—
0
0
10
94
1.06
0.01
1.4
1.2
—
1.06
—
0
7
12
115
1.04
0.00
1.2
1.4
—
—
—
0
0
24
238
1.01
0.00
2.2
1.6
—
—
—
0
0
15
151
0.99
0.00
1.9
1.7
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
7.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
9
0.00
-0.00
0.0
6.7
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
9
90
1.00
-0.00
1.3
1.8
—
—
—
0
0
7
74
0.95
-0.00
1.7
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
7.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
6.0
—
—
—
0
0
6
67
0.89
-0.00
1.3
1.9
—
—
—
0
0
7
74
0.95
-0.00
1.3
1.7
—
—
—
0
0
0
8
0.00
-0.00
0.0
3.4
—
58.00
—
0
8
0
7
0.00
-0.00
0.0
1.7
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: H7_BLINDVISIMPNAS – Unspecified visual impairment (binocular)
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).